Get started
Author

Feifei Song

Observed names: F. Song, FeiFei Song
ORCID: 0000-0002-4700-8064
Observed ORCID: 0000-0002-4700-8064
OpenAlex ID: A5081435176
Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
2019 · Janis V. de la Iglesia, Robbert J.C. Slebos, et al. · Clinical Cancer Research · 116
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study
2021 · Christine H. Chung, Marcelo Bonomi, et al. · Cancers · 60
PDF
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
2022 · Xuefeng Wang, Jameel Muzaffar, et al. · Journal for ImmunoTherapy of Cancer · 40
PDF
Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma
2020 · Ritu Chaudhary, Robbert J. C. Slebos, et al. · Molecular Carcinogenesis · 25
Long noncoding RNA, LINC00460, as a prognostic biomarker in head and neck squamous cell carcinoma (HNSCC).
2020 · Ritu Chaudhary, Xuefeng Wang, et al. · PubMed · 19
EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al. · Cancer Research Communications · 13
PDF
Model-informed experimental design recommendations for distinguishing intrinsic and acquired targeted therapeutic resistance in head and neck cancer
2022 · Santiago D. Cárdenas, Constance J. Reznik, et al. · npj Systems Biology and Applications · 13
PDF
Immune landscape in molecular subtypes of human papillomavirus‐negative head and neck cancer
2023 · Mengyu Xie, Ritu Chaudhary, et al. · Molecular Carcinogenesis · 4
Tobacco smoking is associated with the immune suppressive microenvironment in head and neck squamous cell carcinoma (HNSCC)
2019 · C.H. Chung, J.V. de la Iglesia, et al. · Annals of Oncology · 3
Efficacy of concurrent cetuximab (CTX) and nivolumab (NIVO) in previously untreated recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
2021 · Christine H. Chung, Nabil F. Saba, et al. · Journal of Clinical Oncology · 2
Effects of prexasertib, a CHK1 inhibitor, in the immune microenvironment of head and neck squamous cell carcinoma (HNSCC).
2020 · Ritu Chaudhary, Robbert Slebos, et al. · Journal of Clinical Oncology · 1
Immune profiling of head and neck squamous cell carcinoma (HNSCC) by a multiplex immunofluorescence (mIF) panel using multispectral microscopy.
2018 · Janis De La Iglesia, Laura Martin, et al. · Journal of Clinical Oncology · 1
TABLE 2 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Figure S6 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
TABLE 2 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Table S1 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Table S5 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Figure S1 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Table S1 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
FIGURE 1 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Table S8 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Figure S6 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Figure S2 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
FIGURE 3 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Supplementary Figure S5 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma
2023 · Ritu Chaudhary, Robbert J.C. Slebos, et al.
Works count: 105
Citation count: 297
H-index: 7
I10-index: 7
Year
Topic
Type